Seaport Therapeutics, Inc. Common Stock's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings announcements show how well the company is doing financially, helping investors decide if it's a good investment.
Financial results announcements let investors see if the company is making progress on its goals and managing money wisely.
Quarterly earnings show investors how the company performed early in the year and whether it's on track.
Financial results help investors understand the company's progress and decide if it's worth investing in.
Bylaw changes after going public show how the company is organizing itself to follow new stock market rules.
IPO means the company is raising money from public investors for the first time, making stock available to regular people.
A company filing to go public is preparing to sell stock to everyday investors and become a public company.
Stocky reads Seaport Therapeutics, Inc. Common Stock's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Seaport Therapeutics, Inc. Common Stock's most recent tracked filing was a 10-Q on 3 Aug 2026: Reports second quarter 2026 financial results for investors.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.